Live feed
Filing
SC 13G/A
SC 13G/A0000935836-17-000116·Correvio Pharma Corp.
Schedule 13G ownership disclosure
CARDIOME PHARMA CORP
Security class unavailable · CUSIP: 14159U301
Event date: 2016-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 3,158,816
- Percent of class
- 9.9000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000935836-17-000116
- Form type
- SC 13G/A
- Filer
- Correvio Pharma Corp.
- CIK
- CIK 1036141
- Filed
- Feb 14, 2017
- Reporting period
- Dec 31, 2016
- Description
- Schedule 13G beneficial ownership